ALL KEYWORDS
Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia (ALL)
Related Specialists
Showing 3 of 37
Related Fact Sheets
Related Clinical Trials
Showing 2 of 5
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
- Leukemia & Hematologic Cancers
- Pediatric Cancers
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
- Leukemia & Hematologic Cancers
- Pediatric Cancers